Encyclopedia of Couple and Family Therapy

2019 Edition
| Editors: Jay L. Lebow, Anthony L. Chambers, Douglas C. Breunlin

Adjunctive Psychopharmacology in Couple and Family Therapy

  • Dixie MeyerEmail author
  • Stephanie Barkley
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-49425-8_421

Introduction

This entry reviews five major categories of psychopharmacological medications used to treat mood disorders, anxiety disorders, bipolar disorders, psychotic disorders, and attention-deficit/hyperactivity disorder. The term adjunctive distinguishes how therapists should approach medication. Medication should be viewed as supplemental. Only one role of the therapist is as medication manager with tasks like identifying target symptoms to treat with medications, assessing medication responsiveness, confirming use as directed, coping with side effects, and working with the prescribing physician.

Theoretical Framework

The systemic perspective notes multiple influences on the client. Therapists treat the whole family to use relationships to heal. Working with the family provides the best support for the individual using psychotropic medication. Yet, the medical model should be incorporated into therapy to ensure the client is receiving the best standard of care. For example,...

This is a preview of subscription content, log in to check access.

References

  1. DeSousa, A., & Kalra, G. (2012). Drug therapy of attention deficit hyperactivity disorder: Current trends. Mens Sana Monigraphs, 10, 45–69.CrossRefGoogle Scholar
  2. Girardi, P., Brugnoli, R., Manfredi, G., & Sani, G. (2016). Lithium in bipolar disorder: Optimizing therapy using prolonged-release formulations. Drugs in R&D, 16, 293–302.CrossRefGoogle Scholar
  3. Mancini, K., & Luebbe, A. (2016). Dyadic affective flexibility and emotional inertia in relation to youth psychopathology: An integrated model at two timescales. Clinical Child and Family Psychology Review, 19, 117–133.PubMedCrossRefPubMedCentralGoogle Scholar
  4. McIntosh, A., Cohen, A., Turnbull, N. et al. (2004). Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. National Collaborating Centre for Primary Care.Google Scholar
  5. Meyer, D. (2014). Candidates for Antidepressants: Assessing a history of early life stressors CounselingVistas. Retrieved from http://www.counseling.org/docs/default-source/vistas/article_65.pdf?Sfvrsn=8
  6. Nicolas, G., Desilva, A., Prater, K., & Bronkoski, E. (2009). Empathic family stress as a sign of family connectedness in Haitian immigrants. Family Process, 48, 135–150.PubMedCrossRefPubMedCentralGoogle Scholar
  7. Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72, 136–142.PubMedCrossRefPubMedCentralGoogle Scholar
  8. Poon, S., Sim, K., & Baldessarini, R. (2015). Pharmacological approaches for treatment-resistant bipolar disorder. Current Neuropharmacology, 13, 592–604.PubMedCentralCrossRefGoogle Scholar
  9. Smith, T., Weston, C., & Lieberman, J. (2010). Schizophrenia (maintenance treatment). American Family Physician, 82, 338–339.PubMedPubMedCentralGoogle Scholar
  10. Weitz, E., Hollon, S., Twisk, J., et al. (2015). Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs. pharmacotherapy: An individual patient data meta-analysis. JAMA Psychiatry, 72, 1102–1109.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Saint Louis UniversitySaint LouisUSA

Section editors and affiliations

  • Farrah Hughes
    • 1
  • Allen Sabey
    • 2
  1. 1.Employee Assistance ProgramMcLeod HealthFlorenceUSA
  2. 2.The Family Institute at Northwestern UniversityEvanstonUSA